GROUP ONE TRADING, L.P. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,486
-24.2%
4,5590.0%0.00%
Q1 2023$1,960
-39.0%
4,559
-24.8%
0.00%
Q4 2022$3,211
-19.7%
6,059
+20.8%
0.00%
Q3 2022$4,000
-78.9%
5,014
-69.6%
0.00%
Q2 2022$19,000
-67.2%
16,514
-41.5%
0.00%
Q1 2022$58,000
-70.1%
28,214
-58.2%
0.00%
Q4 2021$194,000
-34.0%
67,443
-2.7%
0.00%
Q3 2021$294,000
-50.6%
69,329
-38.4%
0.00%
-100.0%
Q2 2021$595,000
+307.5%
112,512
+259.0%
0.00%
Q1 2021$146,000
+461.5%
31,340
+295.3%
0.00%
Q4 2020$26,000
-81.0%
7,929
-80.8%
0.00%
Q3 2020$137,000
+59.3%
41,397
+84.4%
0.00%
-100.0%
Q1 2020$86,000
+30.3%
22,446
+104.9%
0.00%
Q4 2019$66,000
-80.8%
10,957
-75.9%
0.00%
-100.0%
Q3 2019$344,000
-77.2%
45,440
-59.3%
0.00%
-78.6%
Q2 2019$1,511,000
+630.0%
111,529
+192.1%
0.01%
+600.0%
Q1 2019$207,000
+80.0%
38,178
-1.4%
0.00%
+100.0%
Q4 2018$115,000
-71.1%
38,714
-20.7%
0.00%
-66.7%
Q3 2018$398,000
+142.7%
48,804
+189.2%
0.00%
+200.0%
Q2 2018$164,000
-48.1%
16,876
-53.6%
0.00%
-66.7%
Q1 2018$316,000
+305.1%
36,335
+690.6%
0.00%
+200.0%
Q2 2017$78,0004,5960.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RA Capital Management 507,191$5,107,0000.50%
Cormorant Asset Management, LP 356,600$3,591,0000.43%
Perceptive Advisors 558,446$5,623,0000.42%
NEXTHERA CAPITAL LP 15,000$151,0000.21%
EMERALD ADVISERS, LLC 237,070$2,387,0000.11%
AUXIER ASSET MANAGEMENT 17,857$180,0000.04%
FEDERATED HERMES, INC. 450,000$4,532,0000.01%
Nationwide Fund Advisors 49,473$498,0000.00%
Catalyst Capital Advisors LLC 348$4,0000.00%
DEUTSCHE BANK AG\ 859$8,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders